Illegal or misused substances: recent trends (2013-2014)

 

eftaacuc.jpg

Tendances n° 96, OFDT, 6 p.
December 2014

This issue of Tendances focuses on the key results of the fourteenth annual TREND (Emerging Trends and New Drugs) survey and the scheme’s seven sites. This issue is divided into two main sections: the first focuses on the highlights of 2013 and the beginning of 2014, with the increasing precariousness of a portion of users, the ecstasy tablet «comeback» in parallel with a more visible MDMA presence, an upsurge in the purity of the heroin circulating in France and the report of two new supply methods. The second section describes consequential phenomena that have been identified in the last few years, but are continuing to develop, and especially the rise in commercial herbal cannabis cultivation, the spread of ketamine use and the increasingly frequent use of morphine sulphate. There is also discussion on the entrenchment of new psychoactive substances. In addition to the TREND and SINTES (National detection system of drugs and toxic substances) observations, this issue benefited from the ethnographic research driven by the ITREND (Internet Tools for Research in Europe on New Drugs) project. Finally, there will be special attention paid to cocaine, whose developing market and use is always closely observed given the drug’s prominent place among illegal substances in France.

Authors: Agnès Cadet-Taïrou, Michel Gandilhon, Magali Martinez, Thomas Néfau

Download the PDF file (1,2 Mo)

Drugs in Europe


2017 EMCDDA European Drug Report

What do the latest data tell us about the European drug market? What are the new trends in drug use among European adults and school students? What are the harms associated with drug use and what is being done to counter them? These and other questions are explored in the 2017 EMCDDA European Drug Report.

Country drug reports

Developed by the EMCDDA, in cooperation with the Reitox national focal points, these graphic-rich reports cover: drug use and public health problems; drug policy and responses and drug supply.

The European Union and the drug phenomenon

The European Union & the drug phenomenon : Frequently asked questions , joint publication between the EMCDDA and the European Commission, october 2010, 12 p.